Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Actuate Therapeutics's total debt was $404.99K at Sep 30, 2026. For fiscal 2025 it was $404.99K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $404.99K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $404.99K | – |
| Q4 FY2025 | Dec 31, 2025 | $404.99K | – |
See a number that looks wrong?